Physician profile
Shefali Patel
NPI 1700097912
$1,355.29
in general payments reported to CMS, 2019-2025
10 companies · $372 in 2025
The $372 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.41 · 2020: $12.42 · 2021: $176 · 2022: $178 · 2023: $156 · 2024: $410 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $938.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $937.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $363.35 | 2019-2025 | Total30, Precision7, Precision 1 |
| Harrow Eye, LLC | $352.94 | 2024-2025 | Vevye |
| Sun Pharmaceutical Industries INC. | $243.73 | 2021-2024 | Cequa |
| Eyevance Pharmaceuticals LLC | $90.94 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $85.01 | 2019-2025 | |
| Rxsight INC | $76.26 | 2024 | Rxsight Injector Cartridge, Rxsight Injector Handpiece, Rxsight Contact Lens |
| Bausch & Lomb Americas INC. | $73.44 | 2022-2025 | Biotrue One Day, Infuse |
| Coopervision INC. | $37.97 | 2021-2025 | Clariti Contact Lens |
| Allergan, INC. | $21.38 | 2021 | |
| Maculogix, INC. | $10.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shefali Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.